Abiotrophia defectiva is a well-known endocarditis pathogen, however it has never been described as a cause of primary aortitis. Here we describe the first published case of thoracic aortitis and an unusual case of aortic graft infection due to A. defectiva, which were both managed conservatively.
Introduction
Abiotrophia defectiva is a commensal of the human oral, gastrointestinal and genitourinary tract, 1 and part of the fastidious nutritionally variant streptococci (NVS). 2, 3 NVS infections carry a high number of bacteriological failures and relapses. 4 Through antimicrobial sensitivity testing (AST), Alberti et al. demonstrated that only 11% of A. defectiva isolates were sensitive to penicillin, whereas 70% were intermediate and 19% resistant. 5 Further studies verified this, and showed that 92, 98 and 100% respectively were sensitive to ceftriaxone. [5] [6] [7] Abiotrophia is primarily known as a causative agent of infective endocarditis, 3, 4, 8 but vascular infections due to A. defectiva have also been described co-occurring with endocarditis or endovascular grafts. 9, 10 To our knowledge this bacterium has not been described as a cause of primary aortitis yet. Here, we describe two cases of aortitis caused by A. defectiva with different pathogenesis.
Case Report #1
A 68-year-old female presented in March 2017 with fever, intermittent chest pain and dyspnea for more than a month. Her medical history included type 2 diabetes mellitus, smoking, hypertension and chronic renal failure grade III.
Her vital parameters were normal and her temperature was 37.8°C. Physical examination was normal except for a known precordial systolic murmur. White blood cell count (WBC) was 16×10 9 /L and CRP 255 mg/L. Troponin T and electrocardiography (ECG) were normal. A computed tomography (CT) of the thorax showed pericardial fluid and 2 cm of bilateral pleural effusion. Transthoracic echocardiography demonstrated a 0.5-1 cm pericardial effusion, a mild aortic stenosis but no signs of endocarditis. Two sets of blood cultures were drawn and empirical treatment with cefotaxime was started.
In 1/4 blood culture bottles (BACTEC Plus Aerobic and Lytic Anaerobic ®) A. defectiva was identified using MALDI-TOF MS. Further evaluation with a transesophageal echocardiography (TEE) revealed two separate vegetations located to the aortic wall in the aortic arch and suspected signs of aortitis ( Figure 1A -C) but no signs of endocarditis. ECG-gated CTangiography confirmed signs of aortitis and two separate vegetations in the aortic arch ( Figure 1D-F) . To narrow therapy, according to MICs in AST derived from E-tests (Table 1) , treatment was changed to penicillin G plus rifampicin. This led to the return of fever and worsening symptoms, which is why penicillin G was changed for ampicillin to maintain a narrow spectrum therapy, despite a slightly higher MIC in Etest (Table 1 , E-test). However, the fever persisted why cefotaxime combined with rifampicin and ciprofloxacin was initiated with a continuous improvement from then on. The pericardial effusion decreased and the pleural fluid was drained bilaterally, with negative cultures and 16S RNA PCR. After seven weeks of intravenous antibiotics she was discharged, with an individualized and prolonged treatment with four months of oral ciprofloxacin and rifampicin. Six months after cessation of therapy the patient was well, afebrile and with normalized CRP.
Case Report #2
A 47-year-old male presented in March 2017 due to intermittent and increasing chest pain for a week. His medical history included surgery of a bicuspid stenotic aortic valve and an aneurysm of the ascending aorta with a bovine biological aortic valve and a supracoronary Polythese® graft two months prior. His vital parameters were normal except for a temperature of 39°C. Physical examination demonstrated a systolic murmur over the aortic valve. WBC was 13 ×10 9 /L and CRP 34 mg/L. Troponin T was normal and ECG was unchanged. Two sets of blood cultures were drawn and empirical treatment with isoxazolylpenicillin was initiated. A CT of the thorax showed a ring of soft tissue attenuation around the graft (Figure 2A ), indicative of inflammation that could be a normal postoperative finding, but in which it was hard to exclude infection. TEE showed no signs of endocarditis.
In 4/4 blood culture bottles (BacT/ALERT FA/FN Plus ®) A. defectiva was identified using MALDI-TOF MS and treatment for a possible prosthetic valve endocarditis was initiated with penicillin G and tobramycin. Initial improvement was seen, however, three weeks after the initiation of therapy an itchy rash and a fever developed. A beta-lactam reaction was suspected and penicillin G was replaced with cefotaxime, but fever persevered. TEE then demonstrated an enlargement of the soft tissue adjacent to the aortic graft, for which reason an aortic graft infection (AGI) was suspected; cefotaxime and tobramycin were changed to meropenem and vancomycin and the patient was transferred for preoperative assessment at the regional Department for Thoracic Surgery and performed an ECG-gated CT-angiography which confirmed progress of the inflammation in the soft tissue surrounding the graft ( Figure  2B ). After the antibiotic switch, the patient stabilized, CRP decreased, the fever and the rash disappeared. A multidisciplinary discussion and a risk-benefit assessment resulted in the decision not to operate him, due to the risk of severe complications and the recently stabilized situation. Intravenous vancomycin was given for an additional 3.5 weeks, after which the patient was asymptomatic and CRP almost normalized, why treatment with clindamycin and rifampicin was initiated. However, after two months, an alanine transaminase (ALT) elevation occurred. Since extended AST had shown high MIC for clindamycin in solution (Table 1) , the treatment was changed to amoxicillin and ALT normalized. Nine months into treatment, a 18 F-FDG Positron Emission Tomography-CT was performed which showed an increased 18 Figure  2C ), why a life-long suppressive therapy was planned. After 10 months follow up, the patient was well and CRP normalized.
Discussion
For the first time in the literature we describe an isolated aortic infection due to A. defectiva, as well as an AGI, two cases with markedly different pathogenesis. Both cases were treated conservatively. Guidelines, however based on weak evidence, are available for endocarditis caused by Abiotrophia, 11, 12 but are lacking for the treatment of aortitis; 13 
According to Sörelius et al. mycotic abdominal aortic aneurysm are defined as a combination of three criteria, i.e. clinical presentation suggestive of infection, laboratory markers suggestive of infection and radiological findings on CT or MRI. 14 In case number one, however, a case with a thoracic location identified prior to the development of an aneurysm, all of these three criteria were met. A. defectiva was identified in only one blood culture using MALDI-TOF MS, however this known endocarditis pathogen, 3, 4, [8] [9] [10] was regarded as a significant finding due to its proposed endovascular adhesiveness and the clinical and radiological evidence of infectious aortitis. 15 A proposed definition, currently under validation, defines AGI by clinical/pathological, radiological and laboratory criteria, where one major and one minor criteria are considered an evident diagnosis of AGI, while three minor criteria are considered a suspected AGI. 16 In regard to this definition, case number two exhibited no major, but four minor criteria, i.e. fever with AGI the most likely cause, radiological signs of perigraft inflammation, positive blood cultures and elevated inflammatory markers pointing towards a suspected AGI. The short time between the operation and the infection suggests that the bacteria were already introduced at surgery.
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In case one, relapse occurred after the change of cefotaxime to penicillin G, despite the low MIC-values on E-test. However, a high minimum bactericidal concentration (MBC) for penicillin was found on extended AST (Table 1) . Nevertheless, the same MIC/MBC pattern was seen for cefotaxime, which when used, led to clinical improvement. This discrepancy between in vitro sensitivity and effect of antibiotics in vivo for NVS infections has been known for some time, 4 and could be in part explained by their in vivo production of exopolysaccharides, i.e. biofilm. 17 MIC-values of clindamycin determined through serial dilution were strikingly increased compared to the E-test for both isolates, a pattern that persisted through several repetitions of testing (Table 1 ). This discrepancy remains without an explanation, and in addition to a potential adverse reaction with elevated ALT in patient two, this led to an unwillingness to use clindamycin and thus to a change of therapy. Finally, rifampicin had low MIC-and MBC-values in both isolates, which is why it was used in both patients due to its known effects on the aforementioned biofilm.
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Conclusions
This report describes for the first time in the literature a case of infectious aortitis caused by A. defectiva, as well as an unusual case of aortic vascular graft infection caused by the same pathogen, where in both cases remission was seen with conservative treatment. Therapeutic challenges in the treatment of A. defectiva are illustrated and examined in this paper. 
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